亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

武漢市威順達生物科技有限公司  

醫藥中間體2,3-二羥基萘(2,3-萘二酚)等

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:朱婷
  • 電話:027-88774309
  • 郵件:1078310132@qq.com
  • 傳真:027-88416321
  • QQ:1078310132
站內搜索
 
榮譽資質
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 2-氯-5-氯甲基噻唑
2-氯-5-氯甲基噻唑
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
過期 長期有效
更新 2012-09-15 09:13
 
詳細信息

2-氯-5-氯甲基噻唑

英文:2-chloro-5-chloromethy1-thiazole

結構式:

分子式:C4H3Cl2NS

分子量:168.04

執行標準:Q/DAWS008-2008

CAS:105827-91-6

技術指標:

指標名稱
 技術指標
 
優質品
 一級品
 
純度%≥
 98.5
 98
 
二氯丙烯%≤
 0.1
 0.1
 
異硫氰基酸脂%≤
 0.5
 1.0
 

情況:本品為無色或微黃色液體,m.p.30°C,b.p:108-110°C/2.4Kpa,室溫時為針狀結晶,不溶于水,溶于二氯甲烷、氯仿、四氯化碳等有機溶劑。

包裝:250kg/塑料桶。

貯存:存放于陰涼通風處

用途:該中間體主要是用于合成噻蟲嗪農藥和醫藥中間體:5-羥甲基噻唑。

©2025 武漢市威順達生物科技有限公司 版權所有   技術支持:化工網   訪問量:17495  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |